2021-11-16-世界卫生组织-Cervical_cancer_Luxembourg_2021_country_profile_1页_64kb

Morbidity and Mortality

• Crude cervical cancer incidence per 100,000 women (2020): Not provided (data may be missing).
• Age-standardized cervical cancer incidence per 100,000 women (2020): Not provided.
• Cumulative risk of cervical cancer ages 0-74 (2020): Not provided.
• Cervical cancer deaths (2019): 2,100 women.
• Mortality-to-incidence ratio (2020): Not provided.
• Population-based cancer registry exists (2021): Yes.

Primary Prevention

• HPV vaccination programme coverage among girls (2020): No data (though national coverage is 60% by age 15).
• HPV included in national vaccination programme (2020): Yes.
• Scale of vaccination programme: Programmatic coverage.
• Year of introduction: 2008.
• Primary target cohort: Girls aged 9-14 years by age 15.
• Programme coverage: 60% among girls aged 9-14 years.
• % of target population vaccinated by age 15: 19% (40% among girls turning 15 in 2020 received the final dose).
• Related risk factors: Tobacco use prevalence (women aged 15+): 40% (2020); Condom use: Data not available; HIV incidence: Not provided (2020).

Secondary Prevention: Screening

• National screening programme for cervical cancer exists (2021): Yes.
• Primary screening test used (2021): Cytology and high-performance test.
• Target age range: 25-69 years.
• Ever screened: 91%.
• % of women screened in last 5 years: 89%.
• Programmes to strengthen early detection at primary health care level: No.
• Clearly defined referral system: Yes.
• Date marked for deletion: dezidradnats-egA lacivrec rof nemow 000 001 rep )9102( recnac (redundant text removed).

Treatment and Supportive Care

• National guidelines exist (2021): Yes.
• Cancer diagnosis and treatment services generally available: Yes.
• Radiation and staff: Not specified.
• Cancer centre: Available at tertiary level.
• Palliative care: Generally available for patients with NCDs.
• WHO Cervical Cancer Elimination Strategy Targets for 2030: Not detailed quantitatively.

HPV Vaccination Details

• Introduction year: 2008.
• Coverage by age 15: 19% vaccinated between ages 9-14.
• % vaccinated by final dose: 40% (girls turning 15 in 2020 received the final dose).

Commentary

• High screening participation (91% ever screened), but limited secondary prevention strengthening at primary care level. Vaccination coverage is moderate, with a gap between national targets and actual uptake. Data on conduction and HIV incidence is not available for the specified lines.